Freeze Drying Market is estimated to reach US$ 2.5 billion by 2032, at an 8.5% CAGR | FMI Study

According to Future Market Insights’ most recent industry analysis, the worldwide Freeze Drying Market was valued at roughly US$ 1.0 Billion in 2021 and is likely to expand at a CAGR close to 8.5% over the forecast period, with an estimated worth of approximately US$ 2.5 Billion in 2032. Freeze drying often referred to as …

Neurology Clinical Trials Market in the United States is expected to be worth US$ 3.7 billion by 2032 | FMI

In 2021, the global Neurology Clinical Trials Market was estimated to be worth approximately US$ 5.4 billion. With a CAGR of 6.3% over the next ten years, the market is expected to be worth nearly US$ 10.5 billion by the end of 2032. Over the forecasted period, the neurology clinical trials market is expected to …

Direct Oral Anticoagulants Market share is anticipated to reach US$ 71.78 Billion by 2032

The direct oral anticoagulants market is expected to grow at a 7.5% CAGR during the forecast period, reaching a market share of US$ 71.78 Billion in 2032, up from US$ 24.26 Billion in 2021, owing to increased FDA and CE mark approval for direct oral anticoagulants. As per comprehensive research conducted by ESOMAR-certified consulting firm …

Multiple Myeloma Diagnostics Market is projected to reach US$ 32.91 billion by 2032

During the forecast period, the multiple myeloma diagnostics market is expected to grow at a promising CAGR of 10.3%. The market is currently worth US$ 13.62 billion and is expected to grow to US$ 32.91 billion by 2032. Multiple plasma cells aid in the fight against numerous illnesses, however the accumulation of malignant plasma cells …

Airway Disease Treatment Market is set to advance at a CAGR of 5.2% 2022 to 2032

The globalairway disease treatment market is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period. LABA-ICS, LAMA-ICS, triple treatment, and other related drugs are among the pharmaceuticals used in combination therapy for COPD. Combination therapy is gaining popularity due to its …

Hepatitis C Virus (HCV) Testing Market is estimated to grow at a CAGR of 5.6% from 2022 to 2032 | FMI

[Report of 297 Pages] By the end of 2022, it is anticipated that the market for hepatitis C virus (HCV) testing will be worth US$733.6 Million. A CAGR of 5.6% has been predicted for the market during the forecast period of 2022 to 2032, with an anticipated closing value of US$ 1341.7 Million. The industry expanded at …

Marburg Virus Disease Therapeutics Market is expected to grow with a 5.5% CAGR from 2023 to 2033.

During the forecast period 2023 to 2033, the Marburg virus disease therapeutics market is expected to grow at a value of 5.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Marburg virus disease therapeutics is expected to rise up to a market valuation of US$ 155 Million. Growth of the market …

Global Dental Chair Market is anticipated to reach US$ 851 Million by 2032, with a CAGR of 5.1%

Future Market Insights, a market research and competitive intelligence provider, states that the global dental chair market size has been valued at US$ 516.5 million in 2022 and is expected to grow to US$ 851 million by 2032. The market is expected to grow at a CAGR of 5.1% between 2022 and 2032, and over …

Orthopedic Prosthetic Devices Market to expand at a CAGR of 4.7% through 2032

During the projected period, the orthopedic prosthetic devices market demand is expected to develop at a 4.7% CAGR, rising from US$ 1.9 billion in 2019 to US$ 2.8 billion by 2027. Orthopaedic prosthetics are external mechanical devices that replace a lost skeletal system body part. It is used to prevent or treat injuries or abnormalities …

Global Pediatric Clinical Trials Market Predicted to Expand with 5.3% CAGR, Reaching US$ 26.47 Billion by 2032

Future Market Insights forecasts a growth rate of 5.3% for the global pediatric clinical trials market demand during the period from 2022 to 2032. Valued at around US$ 15.8 billion in 2022, the market is expected to reach US$ 26.47 billion by 2032, driven by the increasing incidence of pediatric chronic and genetic diseases worldwide. …